Unknown

Dataset Information

Morbidity in Klinefelter syndrome and the effect of testosterone treatment.


ABSTRACT: Klinefelter syndrome (KS; 47,XXY) is the most common sex chromosome abnormality in males (150 per 100,000 males). The condition leads to hypergonadotropic hypogonadism and ever since the condition was described approximately 80 years ago, testosterone treatment has been the cornerstone in care for individuals with KS. However, KS is associated with an array of health-related and socioeconomic challenges and it is becoming progressively clear that proper care for boys and men with KS reaches far beyond simply supplementing with testosterone. There are no widely implemented guidelines for KS care, and studies investigating crucial aspects of testosterone treatment in individuals with KS, including both beneficial and potentially adverse effects, have only begun to emerge during the last deca

SUBMITTER: Chang S 

PROVIDER: S-EPMC7413637 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature